Toll-like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas.
about
Combinatorial treatment with polyI:C and anti-IL6 enhances apoptosis and suppresses metastasis of lung cancer cells.Diminished levels of nasal S100A7 (psoriasin) in seasonal allergic rhinitis: an effect mediated by Th2 cytokinesTargeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma.Investigation of Streptococcus salivarius-mediated inhibition of pneumococcal adherence to pharyngeal epithelial cellsToll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue.Toll-like receptor 3 in Epstein-Barr virus-associated nasopharyngeal carcinomas: consistent expression and cytotoxic effects of its synthetic ligand poly(A:U) combined to a Smac-mimetic.The proteome of Toll-like receptor 3-stimulated human immortalized fibroblasts: implications for susceptibility to herpes simplex virus encephalitisTLR agonists: our best frenemy in cancer immunotherapyAdenomatous polyposis coli genotype-dependent toll-like receptor 4 activity in colon cancer.Upregulation of ATF3 inhibits expression of the pro-inflammatory cytokine IL-6 during Neisseria gonorrhoeae infectionStimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells.PI3K inhibitors in cardiovascular disease.Stimulating natural killer cells to protect against cancer: recent developments.Toll-like receptor 3 stimulation triggers metabolic reprogramming in pharyngeal cancer cell line through Myc, MAPK, and HIF.Modulation of Toll-like receptor signaling in innate immunity by natural productsDifferential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands.Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.Biological Response Modifier in Cancer Immunotherapy.Magnetically attachable stencils and the non-destructive analysis of the contribution made by the underlying matrix to cell migration.Immunohistochemical expression of TLR4 and TLR9 in various grades of oral epithelial dysplasia and squamous cell carcinoma, and their roles in tumor progression: a pilot study.Defective NF-κB signaling in metastatic head and neck cancer cells leads to enhanced apoptosis by double-stranded RNA.Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.Rapid nodal staging of head and neck cancer surgical specimens with flow cytometric analysis.NET-producing CD16high CD62Ldim neutrophils migrate to tumor sites and predict improved survival in patients with HNSCC.Nod-like receptors in head and neck squamous cell carcinoma.Bufalin Suppresses Migration and Invasion of Hepatocellular Carcinoma Cells Elicited by Poly (I:C) Therapy.Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosisCandida Immunity
P2860
Q33779298-1A2A1300-519D-4101-85DB-9497DC2AC373Q35780340-6BB9355D-1C89-4DCD-9DD4-1904963139A8Q35833184-5EB8FB1A-6836-4A4E-ABA3-DD2C6FA033C7Q36146974-7851BCBB-E086-4AC4-A32B-25A7D528F592Q36671862-5A3CD8C0-FFE5-4FA2-A74F-F59CDDBE5CD8Q36689480-6E8AD9F5-C607-41C7-A24F-0CAEF90727F9Q36807516-6CB80DA9-54F4-45B7-90FA-947EE40B7629Q36850457-AF825E84-6789-430C-AC16-8DBB66E5B41CQ36946612-66F9C420-C32E-49DE-85DA-CC688C96ECAEQ37228249-0640A0D6-3507-4CB7-B74E-444687941017Q37696181-40AC0444-F20D-42E0-BF3E-7AABBAD50AF4Q37772192-4500596D-BC21-4DB3-8721-9F8D433B4372Q37877269-36F25457-99A2-4C5D-92A0-C9A9061B4027Q38734150-BEA8E7DD-8D50-4C32-8FF6-B8E12CF92A1FQ38743095-BD261113-4E41-40AE-961E-BC80236112CEQ38781955-2A3540A5-C29F-4B64-B85D-9B2C6BA05B52Q38831072-069E08A6-5F05-4C9C-A7E9-0500E0538D63Q38848213-7BAA7111-A845-48F1-A231-DD6C43C49012Q39287153-875AA6FC-4C0B-46B6-8D88-13D43875166DQ39423531-AEB797A4-6851-4EE0-865F-740727E599D0Q39447134-226A7813-B1C5-43FD-B7ED-388CECD44613Q47250120-60700D59-DDA5-44CB-B5EE-4E7589FB2787Q47435520-6F6B066D-A501-4D1E-B10F-8860B9E9BCDBQ48181012-BA227118-963A-4D82-9FB5-D646C04260B9Q53089451-F19EC3C8-F7B0-40EF-8367-4A7A79E64C78Q54112790-C5EBA808-24CD-47A8-98C1-6CCDF3DC7A5EQ55003290-4C0B0B7A-9178-44B8-B88D-8B36D875C01DQ58695329-F349D18A-A812-462F-8B0E-8D24B7B726ACQ59072636-C3A130E9-402A-4754-A329-15CA8B3927C3
P2860
Toll-like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Toll-like receptor agonists in ...... neck squamous cell carcinomas.
@en
Toll-like receptor agonists in ...... neck squamous cell carcinomas.
@nl
type
label
Toll-like receptor agonists in ...... neck squamous cell carcinomas.
@en
Toll-like receptor agonists in ...... neck squamous cell carcinomas.
@nl
prefLabel
Toll-like receptor agonists in ...... neck squamous cell carcinomas.
@en
Toll-like receptor agonists in ...... neck squamous cell carcinomas.
@nl
P2093
P2860
P1433
P1476
Toll-like receptor agonists in ...... neck squamous cell carcinomas.
@en
P2093
Anne Månsson
Camilla Rydberg
Lars-Olaf Cardell
Rolf Uddman
P2860
P304
P356
10.1111/J.1365-2567.2008.03041.X
P433
P577
2008-12-26T00:00:00Z